Source: British Heart Foundation
Follow this link for full text
Date of publication: August 2017
Publication type: Research
In a nutshell: Scientists have, for the first time, used gene-editing to correct the genetic mutation for a heart condition known as hypertrophic cardiomyopathy (HCM). This new advance could mean that it would be possible to correct the defect at the earliest stage of embryonic development so that the defect would not be passed on to future generations.
Length of publication: 1 webpage
Some important notes: Please contact your local NHS library if you cannot access the full text. Follow this link to find your local NHS library.
Acknowledgement: British Heart Foundation